vs

Side-by-side financial comparison of Health Catalyst, Inc. (HCAT) and Townsquare Media, Inc. (TSQ). Click either name above to swap in a different company.

Townsquare Media, Inc. is the larger business by last-quarter revenue ($106.5M vs $74.7M, roughly 1.4× Health Catalyst, Inc.). Townsquare Media, Inc. runs the higher net margin — -4.9% vs -121.9%, a 117.0% gap on every dollar of revenue. On growth, Health Catalyst, Inc. posted the faster year-over-year revenue change (-6.2% vs -9.6%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $9.2M). Over the past eight quarters, Townsquare Media, Inc.'s revenue compounded faster (3.4% CAGR vs -0.0%).

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

Townsquare Media, Inc. is an American radio network and media company based in Purchase, New York. The company started in radio and expanded into digital media toward the end of the 2000s, starting with the acquisition of the MOG Music Network. As of June 2024, Townsquare was the third-largest AM–FM operator in the country, owning 349 radio stations in 74 markets.

HCAT vs TSQ — Head-to-Head

Bigger by revenue
TSQ
TSQ
1.4× larger
TSQ
$106.5M
$74.7M
HCAT
Growing faster (revenue YoY)
HCAT
HCAT
+3.4% gap
HCAT
-6.2%
-9.6%
TSQ
Higher net margin
TSQ
TSQ
117.0% more per $
TSQ
-4.9%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$447.0K more FCF
HCAT
$9.6M
$9.2M
TSQ
Faster 2-yr revenue CAGR
TSQ
TSQ
Annualised
TSQ
3.4%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCAT
HCAT
TSQ
TSQ
Revenue
$74.7M
$106.5M
Net Profit
$-91.0M
$-5.2M
Gross Margin
24.1%
Operating Margin
-115.3%
9.5%
Net Margin
-121.9%
-4.9%
Revenue YoY
-6.2%
-9.6%
Net Profit YoY
-340.3%
-121.2%
EPS (diluted)
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCAT
HCAT
TSQ
TSQ
Q4 25
$74.7M
$106.5M
Q3 25
$76.3M
$106.8M
Q2 25
$80.7M
$115.4M
Q1 25
$79.4M
$98.7M
Q4 24
$79.6M
$117.8M
Q3 24
$76.4M
$115.3M
Q2 24
$75.9M
$118.2M
Q1 24
$74.7M
$99.6M
Net Profit
HCAT
HCAT
TSQ
TSQ
Q4 25
$-91.0M
$-5.2M
Q3 25
$-22.2M
$-5.9M
Q2 25
$-41.0M
$1.6M
Q1 25
$-23.7M
$-2.0M
Q4 24
$-20.7M
$24.6M
Q3 24
$-14.7M
$10.8M
Q2 24
$-13.5M
$-49.2M
Q1 24
$-20.6M
$1.1M
Gross Margin
HCAT
HCAT
TSQ
TSQ
Q4 25
24.1%
Q3 25
52.6%
26.2%
Q2 25
28.3%
Q1 25
23.2%
Q4 24
31.6%
Q3 24
47.5%
27.3%
Q2 24
27.7%
Q1 24
22.8%
Operating Margin
HCAT
HCAT
TSQ
TSQ
Q4 25
-115.3%
9.5%
Q3 25
-22.9%
5.6%
Q2 25
-46.0%
18.2%
Q1 25
-25.4%
7.2%
Q4 24
-22.0%
18.1%
Q3 24
-17.9%
13.1%
Q2 24
-20.8%
-18.1%
Q1 24
-30.5%
6.7%
Net Margin
HCAT
HCAT
TSQ
TSQ
Q4 25
-121.9%
-4.9%
Q3 25
-29.1%
-5.5%
Q2 25
-50.8%
1.4%
Q1 25
-29.9%
-2.0%
Q4 24
-26.0%
20.8%
Q3 24
-19.3%
9.4%
Q2 24
-17.8%
-41.7%
Q1 24
-27.6%
1.1%
EPS (diluted)
HCAT
HCAT
TSQ
TSQ
Q4 25
$-1.29
Q3 25
$-0.32
$-0.36
Q2 25
$-0.59
$0.09
Q1 25
$-0.35
$-0.12
Q4 24
$-0.33
$1.76
Q3 24
$-0.24
$0.63
Q2 24
$-0.23
$-3.26
Q1 24
$-0.35
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCAT
HCAT
TSQ
TSQ
Cash + ST InvestmentsLiquidity on hand
$95.7M
$4.8M
Total DebtLower is stronger
$153.3M
$433.0M
Stockholders' EquityBook value
$245.8M
$-41.0M
Total Assets
$502.6M
$528.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCAT
HCAT
TSQ
TSQ
Q4 25
$95.7M
$4.8M
Q3 25
$91.5M
$3.2M
Q2 25
$97.3M
$3.2M
Q1 25
$342.0M
$5.5M
Q4 24
$392.0M
$33.0M
Q3 24
$387.3M
$21.8M
Q2 24
$308.3M
$28.5M
Q1 24
$327.8M
$56.6M
Total Debt
HCAT
HCAT
TSQ
TSQ
Q4 25
$153.3M
$433.0M
Q3 25
$153.1M
$437.6M
Q2 25
$153.0M
$439.7M
Q1 25
$382.9M
$448.4M
Q4 24
$382.4M
$465.8M
Q3 24
$345.0M
$476.7M
Q2 24
$487.1M
Q1 24
$500.1M
Stockholders' Equity
HCAT
HCAT
TSQ
TSQ
Q4 25
$245.8M
$-41.0M
Q3 25
$331.9M
$-34.0M
Q2 25
$347.5M
$-27.1M
Q1 25
$376.8M
$-26.8M
Q4 24
$365.2M
$-28.4M
Q3 24
$355.0M
$-52.5M
Q2 24
$357.0M
$-64.1M
Q1 24
$357.2M
$1.8M
Total Assets
HCAT
HCAT
TSQ
TSQ
Q4 25
$502.6M
$528.6M
Q3 25
$587.1M
$539.2M
Q2 25
$616.2M
$545.7M
Q1 25
$891.5M
$544.5M
Q4 24
$858.9M
$580.4M
Q3 24
$813.0M
$565.4M
Q2 24
$691.7M
$579.6M
Q1 24
$695.1M
$636.7M
Debt / Equity
HCAT
HCAT
TSQ
TSQ
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24
271.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCAT
HCAT
TSQ
TSQ
Operating Cash FlowLast quarter
$9.9M
$12.6M
Free Cash FlowOCF − Capex
$9.6M
$9.2M
FCF MarginFCF / Revenue
12.9%
8.6%
Capex IntensityCapex / Revenue
0.4%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K
$15.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCAT
HCAT
TSQ
TSQ
Q4 25
$9.9M
$12.6M
Q3 25
$-464.0K
$7.9M
Q2 25
$-9.0M
$10.2M
Q1 25
$280.0K
$-66.0K
Q4 24
$-3.5M
$28.2M
Q3 24
$6.2M
$9.9M
Q2 24
$1.6M
$9.0M
Q1 24
$10.3M
$1.7M
Free Cash Flow
HCAT
HCAT
TSQ
TSQ
Q4 25
$9.6M
$9.2M
Q3 25
$-719.0K
$4.3M
Q2 25
$-9.2M
$6.4M
Q1 25
$-390.0K
$-4.5M
Q4 24
$-3.9M
$24.5M
Q3 24
$5.5M
$4.8M
Q2 24
$1.3M
$4.8M
Q1 24
$10.1M
$-2.8M
FCF Margin
HCAT
HCAT
TSQ
TSQ
Q4 25
12.9%
8.6%
Q3 25
-0.9%
4.1%
Q2 25
-11.4%
5.5%
Q1 25
-0.5%
-4.6%
Q4 24
-4.9%
20.8%
Q3 24
7.2%
4.1%
Q2 24
1.7%
4.0%
Q1 24
13.5%
-2.8%
Capex Intensity
HCAT
HCAT
TSQ
TSQ
Q4 25
0.4%
3.2%
Q3 25
0.3%
3.3%
Q2 25
0.3%
3.3%
Q1 25
0.8%
4.5%
Q4 24
0.5%
3.1%
Q3 24
0.9%
4.4%
Q2 24
0.4%
3.6%
Q1 24
0.3%
4.4%
Cash Conversion
HCAT
HCAT
TSQ
TSQ
Q4 25
Q3 25
Q2 25
6.51×
Q1 25
Q4 24
1.15×
Q3 24
0.91×
Q2 24
Q1 24
1.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

TSQ
TSQ

Broadcast Advertising Segment$46.4M44%
Digital Advertising Segment$41.7M39%
Subscription Digital Marketing Solutions Segment$18.4M17%

Related Comparisons